|
1
|
National Cancer Institute. Cancer
Statistics: SEER stat fact sheets: esophagus. http://seer.cancer.gov/statfacts/html/esoph.html.
Accessed January 20, 2013
|
|
2
|
Zhang SW, Lei ZL, Li GL, Zou XL, Zhao P
and Chen WQ: A report of cancer incidence and mortality from 34
cancer registries in China, 2006. China Cancer. 19:356–365.
2010.
|
|
3
|
Gholipour C, Shalchi RA and Abbasi M: A
histopathological study of esophageal cancer on the western side of
the Caspian littoral from 1994 to 2003. Dis Esophagus. 21:322–327.
2008. View Article : Google Scholar
|
|
4
|
Tran GD, Sun XD, Abnet CC, et al:
Prospective study of risk factors for esophageal and gastric
cancers in the Linxian general population trial cohort in China.
Int J Cancer. 113:456–463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun XD, Yu JM, Fan XL, Ren RM, Li MH and
Zhang GL: Randomized clinical study of surgery versus radiotherapy
alone in the treatment of resectable esophageal cancer in the
chest. Zhonghua Zhong Liu Za Zhi. 28:784–787. 2006.(In
Chinese).
|
|
6
|
Abrams JA, Buono DL, Strauss J, McBride
RB, Hershman DL and Neugut AI: Esophagectomy compared with
chemoradiation for early stage esophageal cancer in the elderly.
Cancer. 115:4924–4933. 2009. View Article : Google Scholar
|
|
7
|
Smith TJ, Ryan LM, Douglass HO Jr, et al:
Combined chemoradiotherapy vs. radiotherapy alone for early stage
squamous cell carcinoma of the esophagus: a study of the Eastern
Cooperative Oncology Group. Int J Radiat Oncol Biol Phys.
42:269–276. 1998. View Article : Google Scholar
|
|
8
|
Wobbes T, Baron B, Paillot B, et al:
Prospective randomised study of split-course radiotherapy versus
cisplatin plus split-course radiotherapy in inoperable squamous
cell carcinoma of the oesophagus. Eur J Cancer. 37:470–477. 2001.
View Article : Google Scholar
|
|
9
|
National Comprehensive Cancer Network.
Clinical Practice Guidelines in Oncology™ version 2. 2012,
http://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
Accessed January 2, 2013
|
|
10
|
Freeman RK, Ascioti AJ and Mahidhara RJ:
Palliative therapy for patients with unresectable esophageal
carcinoma. Surg Clin North Am. 92:1337–1351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ikeda E, Kojima T, Kaneko K, et al:
Efficacy of concurrent chemoradiotherapy as a palliative treatment
in stage IVB esophageal cancer patients with dysphasia. Jpn J Clin
Oncol. 41:964–972. 2011. View Article : Google Scholar
|
|
12
|
Law S, Wong KH, Kwok KF, Chu KM and Wong
J: Predictive factors for postoperative pulmonary complications and
mortality after esophagectomy for cancer. Ann Surg. 240:791–800.
2004. View Article : Google Scholar
|
|
13
|
Nishino M, Jackman DM, Hatabu H, et al:
New Response Evaluation Criteria in Solid Tumours (RECIST)
guidelines for advanced non-small cell lung cancer: comparison with
original RECIST and impact on assessment of tumor response to
targeted therapy. AJR Am J Roentgenol. 195:W221–W228. 2010.
View Article : Google Scholar
|
|
14
|
National Cancer Institute. Cancer Therapy
Evaluation Program: protocol development. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/#ctc_30.htm.
Accessed January 13, 2013
|
|
15
|
Mak HK, Mamon HJ, Ryan DP, et al: Toxicity
and outcomes after chemoradiation for esophageal cancer in patients
age 75 or older. Dis Esophagus. 23:316–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Servagi-Vernat S, Bosset M, Crehange G, et
al: Feasibility of chemoradiotherapy for oesophageal cancer in
elderly patients aged >or=75 years: a prospective, single-arm
phase II study. Drug Aging. 26:255–262. 2009.
|
|
17
|
Herskovic A, Martz K, al-Sarraf M, et al:
Combined chemotherapy and radiotherapy compared with radiotherapy
alone in patients with cancer of the esophagus. N Engl J Med.
326:1593–1598. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cooper JS, Guo MD, Herskovic A, et al:
Chemoradiotherapy of locally advanced esophageal cancer: long-term
follow-up of a prospective randomized trial (RTOG 85-01). Radiation
Therapy Oncology Group. JAMA. 281:1623–1627. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anderson SE, Minsky BD, Bains M, Hummer A,
Kelsen D and Ilson DH: Combined modality chemoradiation in elderly
oesophageal cancer patients. Br J Cancer. 96:1823–1827. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tougeron D, Hamidou H, Scotté M, Di Fiore
F, Antonietti M, Paillot B and Michel P: Esophageal cancer in the
elderly: an analysis of the factors associated with treatment
decisions and outcomes. BMC Cancer. 10:5102010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tougeron D, Di Fiore F, Thureau S, et al:
Safety and outcome of definitive chemoradiaotherapy in elderly
patients with oesophageal cancer. Br J Cancer. 99:1586–1592. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Go SI, Sup Lee W, Hee Kang M, et al:
Response to concurrent chemoradiotherapy as a prognostic marker in
elderly patients with locally advanced esophageal cancer. Tumori.
98:225–232. 2012.PubMed/NCBI
|
|
23
|
Coia LR, Minsky BD, Berkey BA, et al:
Outcome of patients receiving radiation for cancer of the
esophagus: results of the 1992–1994 Patterns of Care Study. J Clin
Oncol. 18:455–462. 2000.
|
|
24
|
Polee MB, Hop WC, Kok TC, et al:
Prognostic factors for survival in patients with advanced
oesophageal cancer treated with cisplatin-based combination
chemotherapy. Br J Cancer. 89:2045–2050. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rohatgi P, Swisher SG, Correa AM, et al:
Characterization of pathologic complete response after preoperative
chemoradiotherapy in carcinoma of the esophagus and outcome after
pathologic complete response. Cancer. 104:2365–2372. 2005.
View Article : Google Scholar
|
|
26
|
Di Fiore F, Lecleire S, Rigal O, et al:
Predictive factors of survival in patients treated with definitive
chemoradiotherapy for squamous cell esophageal carcinoma. World J
Gastroenterol. 12:4185–4190. 2006.PubMed/NCBI
|
|
27
|
Takeuchi S, Ohtsu A, Doi T, et al: A
retrospective study of definitive chemoradiotherapy for elderly
patients with esophageal cancer. Am J Clin Oncol. 30:607–611. 2007.
View Article : Google Scholar : PubMed/NCBI
|
